Similar articles

• Efficacy of the latest generation of antibody assays for (early) detection of HIV 1 and HIV 2 infection.

  Lelie PN, van der Poel CL, Reesink HW, Huisman HG, Boucher CA, Goudsmit J. Lelie PN, et al. Vox Sang. 1989;56(1):59-61. doi: 10.1111/j.1423-0410.1989.tb03051.x. Vox Sang. 1989. PMID: 2916337 No abstract available.
• An ELISA-inhibition assay for antibody to human immunodeficiency virus core antigen (p24).

  Povolotsky J, Gold JW, Darminin P, Chein N, Baron P, Armstrong D. Povolotsky J, et al. J Virol Methods. 1990 Oct;30(1):109-14. doi: 10.1016/0166-0934(90)90048-k. J Virol Methods. 1990. PMID: 2128300
• Epitope location of 13 anti-gag HIV-1 monoclonal antibodies using oligopeptides and their cross reactivity with HIV-2.

  Ferns RB, Partridge JC, Spence RP, Hunt N, Tedder RS. Ferns RB, et al. AIDS. 1989 Dec;3(12):829-34. doi: 10.1097/00002030-198912000-00008. AIDS. 1989. PMID: 2483619
• [Current status of HIV serology].

  Eberle J, Gürtler L, Deinhardt F. Eberle J, et al. Verh Dtsch Ges Inn Med. 1989;95:406-9. Verh Dtsch Ges Inn Med. 1989. PMID: 2690511 Review. German. No abstract available.
• HIV testing. State of the art.

  Sloand EM, Pitt E, Chiarello RJ, Nemo GJ. Sloand EM, et al. JAMA. 1991 Nov 27;266(20):2861-6. doi: 10.1001/jama.266.20.2861. JAMA. 1991. PMID: 1942454 Review. No abstract available.